FDA Grants Accelerated Approval to GSK’s Jemperli for Rectal Cancer
The FDA approved Jemperli for adults with MSI-H/dMMR stage II/III locally advanced rectal cancer, based on phase II AZUR-1 data. The review continues under Project Orbis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.